Skip to main content
. Author manuscript; available in PMC: 2023 Jun 12.
Published in final edited form as: Arch Clin Exp Dermatol. 2021 Apr 30;3(1):119. doi: 10.46527/2583-6374.119

TABLE 1.

Part 1 Patient Demographics.

Age Gender Location Type Breslow’s Ulceration Mitosis Stage
48 M R chest/abdomen superficial spreading >5 mm Y 5 IIIB (T4b, N1a, Mx)
71 M R chest superficial spreading 2.33 mm N 1 IIIB (T3b, N2a, M0)
49 F R chest superficial spreading >1.53 mm N 2 IIIA (T2a, N1a, M0)
74 M Right back superficial spreading 1.9 mm N 1 IB (T2a, N0, Mx)
42 F Mid back superficial spreading 0.88 mm N 1 IB (T1b, N0, Mx)
90 M Left back MIS superficial spreading n/a N n/a 0(Tis, Nx, Mx)
41 F L chest MIS superficial spreading n/a N n/a 0(Tis, Nx, Mx)
72 F R cheek MIS Lentigo Maligna n/a N n/a 0(Tis, Nx, Mx)
60 M R cheek MIS Lentigo Maligna n/a N n/a 0(Tis, Nx, Mx)
92 M R ear lobe MIS Lentigo Maligna n/a N n/a 0(Tis, Nx, Mx)